6,542 followers
New Research: Improving the response to lenvatinib in partial responders using a Constrained-Disorder-Principle-based second-generation artificial intelligence-therapeutic regimen: a proof-of-concept open-labeled clinical trial https://t.co/63gBN9R5Jk #Fro